chr11-5226718-G-T
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PM1PM2PP3_Strong
The NM_000518.5(HBB):c.174C>A(p.Asn58Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. N58D) has been classified as Uncertain significance.
Frequency
Consequence
NM_000518.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
HBB | NM_000518.5 | c.174C>A | p.Asn58Lys | missense_variant | 2/3 | ENST00000335295.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
HBB | ENST00000335295.4 | c.174C>A | p.Asn58Lys | missense_variant | 2/3 | 1 | NM_000518.5 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 36
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Oct 01, 2021 | The Hb G-Ferrara variant (HBB c.174C>A; p.Asn58Lys, also known as Asn57Lys when numbered from the mature protein, rs35278874) is reported as a slightly unstable hemoglobin, but shows normal oxygen affinity, Bohr effect and cooperativity (HbVar database and references therein). In one study, the data suggested that Hb G-Ferrara in combination with Hb S could result in sickle cell disease (see Canizares 1983, discussed in Silva 2013); however, a later study suggests Hb G-Ferrara is not associated with sickle cell disease (Silva 2013). The Hb G-Ferrara variant is absent from the Genome Aggregation Database, indicating it is not a common polymorphism. The asparagine at codon 58 is highly conserved, but computational analyses are uncertain whether this variant is neutral or deleterious (REVEL: 0.639). Due to limited information, the clinical significance of this variant is uncertain at this time. REFERENCES Link to HbVar database for Hb G-Ferrara: http://globin.bx.psu.edu/cgi-bin/hbvar/query_vars3?mode=output&display_format=page&i=344 Canizares ME et al. Hemoglobinopatia S con interaccion de la HbS y la Hb G-Ferrara [Hemoglobinopathy S with an interaction of HbS and Hb G-Ferrara]. Sangre (Barc). 1983;28(6):770-4. Spanish. PMID: 6673168. Silva MR et al. Clinical and molecular characterization of hemoglobin Maputo [beta 47 (CD6) Asp > Tyr HBB: c.142G > T] and G-Ferrara [beta 57 (E1) Asn > Lys HBB: c.174C > A] in a newborn screening in Brazil. Int J Lab Hematol. 2013 Dec;35(6):e1-4. PMID: 23279838. - |
HEMOGLOBIN G (FERRARA) Other:1
other, no assertion criteria provided | literature only | OMIM | Dec 12, 2017 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at